River Vision Development

company

About

River Vision Development develops a protein therapy for the treatment of Graves’ orbitopathy.

  • 1 - 10

Details

Industries
Health Care,Therapeutics,Wellness
Founded date
Jan 1, 2011
Number Of Employee
1 - 10
Operating Status
Active

River Vision Development develops RV001, a protein therapy for the treatment of Graves’ Orbitopathy (GO).

River Vision Development was founded in 2011 and is based in New York, New York.